Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Sarpogrelate (Primary)
- Indications Diabetic nephropathies
- Focus Adverse reactions; Therapeutic Use
- Acronyms SONATA
- Sponsors Yuhan
- 26 Apr 2021 Status changed from active, no longer recruiting to completed.
- 09 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 Jun 2013 New trial record